TERNS PHARMACEUTICALS INC (TERN) Stock News

USA - Nasdaq - NASDAQ:TERN - US8808811074 - Common Stock

45 USD

-2.09 (-4.44%)

Last: 12/12/2025, 8:04:13 PM

45.5 USD

+0.5 (+1.11%)

After Hours: 12/12/2025, 8:04:13 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

TERN Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Terns Pharmaceuticals, Inc.

Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

2 days ago - By: Terns Pharmaceuticals, Inc.

Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

4 days ago - By: Terns Pharmaceuticals, Inc.

Terns Announces Pricing of Upsized $650 Million Public Offering

4 days ago - By: Terns Pharmaceuticals, Inc.

Terns Announces Pricing of Upsized $650 Million Public Offering

4 days ago - By: Terns Pharmaceuticals, Inc.

Terns Announces Proposed Public Offering

4 days ago - By: Terns Pharmaceuticals, Inc.

Terns Announces Proposed Public Offering

10 days ago - By: The Motley Fool - Mentions: MRUS NUVL XENE COGT ...

Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors

a month ago - By: Benzinga - Mentions: SGML COCO IVVD CROX ...

Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday

a month ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London

a month ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London

a month ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

a month ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

a month ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

a month ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

a month ago - By: Benzinga - Mentions: SGHC EXPD XMTR HSIC ...

Henry Schein, Sanmina, Wingstop, Waters And Other Big Stocks Moving Higher On Tuesday

a month ago - By: Terns Pharmaceuticals, Inc.

Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting

a month ago - By: Terns Pharmaceuticals, Inc.

Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting

2 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity

2 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity

2 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

2 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

3 months ago - By: The Motley Fool - Mentions: RYTM

2 Under-the-Radar Stocks That Could Soar

4 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals to Host an Educational Webinar on TERN-701 for Investors in Advance of Phase 1 Data Expected in Fourth Quarter 2025

4 months ago - By: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals to Host an Educational Webinar on TERN-701 for Investors in Advance of Phase 1 Data Expected in Fourth Quarter 2025